As Novo Nordisk and Eli Lilly struggle to keep up with soaring demand for their popular diabetes and weight loss drugs, ...
Novo Nordisk A/S, the maker of Ozempic and Wegovy, lost an office building at its Danish headquarters complex due to a ...
Ozempic has boomed in populartity since it was first issued Stephen Fry thought things were too good to be true. Having ...
Eli Lilly and Novo Nordisk have staged big rallies. Here’s how investors can approach this potentially huge opportunity.
The boom in weight loss drugs could have a massive impact on the travel industry, which we discuss in this issue of the Skift ...
Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and ...
Millions of people are injecting themselves with weight loss drugs and the firms that make them have seen their share prices ...
Weight loss drugs are rising in popularity, and food companies are cooking up new ways to win over those consumers.
Online pharmaceutical brands Hims & Hers are introducing a weight-loss drug containing a compounded form of semaglutide, the ...
House price rises will be curbed this year as a result of “higher for longer” interest rates, a firm of leading economists ...
Giving obese children semaglutide could reduce their risk by 90 per cent. It comes after Diabetes UK revealed obesity has ...
No single individual’s best guess about where an index will be in more than seven months should be of interest. And RIP Ivan ...